182 related articles for article (PubMed ID: 9751146)
1. Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain.
Porcella A; Gessa GL; Pani L
Eur J Neurosci; 1998 May; 10(5):1743-51. PubMed ID: 9751146
[TBL] [Abstract][Full Text] [Related]
2. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.
Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D
Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821
[TBL] [Abstract][Full Text] [Related]
5. Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function.
Alonso R; Voutsinos B; Fournier M; Labie C; Steinberg R; Souilhac J; Le Fur G; Soubrié P
Neuroscience; 1999; 91(2):607-20. PubMed ID: 10366018
[TBL] [Abstract][Full Text] [Related]
6. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
[TBL] [Abstract][Full Text] [Related]
7. Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats.
Corchero J; García-Gil L; Manzanares J; Fernández-Ruiz JJ; Fuentes JA; Ramos JA
Life Sci; 1998; 63(10):843-50. PubMed ID: 9734704
[TBL] [Abstract][Full Text] [Related]
8. Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.
Petitet F; Jeantaud B; Reibaud M; Imperato A; Dubroeucq MC
Life Sci; 1998; 63(1):PL1-6. PubMed ID: 9667767
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of Fos protein induction in rat striatum and nucleus accumbens following repeated administration of delta9-tetrahydrocannabinol.
Miyamoto A; Yamamoto T; Ohno M; Watanabe S
Brain Res; 1997 Jul; 763(1):137-40. PubMed ID: 9272839
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
Carta G; Nava F; Gessa GL
Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
[TBL] [Abstract][Full Text] [Related]
11. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
Järbe TU; Lamb RJ; Lin S; Makriyannis A
Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
[TBL] [Abstract][Full Text] [Related]
12. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
Nye HE; Nestler EJ
Mol Pharmacol; 1996 Apr; 49(4):636-45. PubMed ID: 8609891
[TBL] [Abstract][Full Text] [Related]
13. Role of Dopamine Type 1 Receptors and Dopamine- and cAMP-Regulated Phosphoprotein Mr 32 kDa in Δ9-Tetrahydrocannabinol-Mediated Induction of ΔFosB in the Mouse Forebrain.
Lazenka MF; Tomarchio AJ; Lichtman AH; Greengard P; Flajolet M; Selley DE; Sim-Selley LJ
J Pharmacol Exp Ther; 2015 Sep; 354(3):316-27. PubMed ID: 26099530
[TBL] [Abstract][Full Text] [Related]
14. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja.
MacGibbon GA; Lawlor PA; Bravo R; Dragunow M
Brain Res Mol Brain Res; 1994 Apr; 23(1-2):21-32. PubMed ID: 8028480
[TBL] [Abstract][Full Text] [Related]
15. Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex.
Kontkanen O; Lakso M; Wong G; Castrén E
Neuropsychopharmacology; 2002 Aug; 27(2):152-62. PubMed ID: 12093589
[TBL] [Abstract][Full Text] [Related]
16. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
17. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Manzanares J; Corchero J; Fuentes JA
Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
[TBL] [Abstract][Full Text] [Related]
18. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain.
Allen KV; McGregor IS; Hunt GE; Singh ME; Mallet PE
Neuropharmacology; 2003 Feb; 44(2):264-74. PubMed ID: 12623225
[TBL] [Abstract][Full Text] [Related]
19. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.
Tanda G; Loddo P; Di Chiara G
Eur J Pharmacol; 1999 Jul; 376(1-2):23-6. PubMed ID: 10440085
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
Tanda G; Pontieri FE; Di Chiara G
Science; 1997 Jun; 276(5321):2048-50. PubMed ID: 9197269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
